Do CT findings of Mycobacterium abscessus infection in patients with Cystic Fibrosis predict outcome?

V. Holt (Leeds, United Kingdom), L. Mohan Das (Leeds, United Kingdom), P. Whitaker (Leeds, United Kingdom), G. Spoletini (Leeds, United Kingdom), I. Clifton (Leeds, United Kingdom), C. Etherington (Leeds, United Kingdom), D. Peckham (Leeds, United Kingdom)

Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Session: Advances in care and monitoring of cystic fibrosis
Session type: Oral Presentation
Number: 2129
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Holt (Leeds, United Kingdom), L. Mohan Das (Leeds, United Kingdom), P. Whitaker (Leeds, United Kingdom), G. Spoletini (Leeds, United Kingdom), I. Clifton (Leeds, United Kingdom), C. Etherington (Leeds, United Kingdom), D. Peckham (Leeds, United Kingdom). Do CT findings of Mycobacterium abscessus infection in patients with Cystic Fibrosis predict outcome?. 2129

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019


A patient with cystic fibrosis and Mycobacterium abscessus infection
Source: International Congress 2018 – CC1 Lung transplantation
Year: 2018


LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis
Source: Eur Respir J 2015; 46: 707-716
Year: 2015



Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020
Year: 2020



Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018

Incidence and outcomes of Mycobacterium abscesssus infections in non-Cystic Fibrosis patients
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Pulmonary Mycobacterium abscessus: can we identify the road to improved outcomes?
Source: Eur Respir J, 54 (1) 1901121; 10.1183/13993003.01121-2019
Year: 2019



Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients
Source: Eur Respir J 2013; 41: 1101-1106
Year: 2013



Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy
Source: Eur Respir J, 50 (1) 1602525; 10.1183/13993003.02525-2016
Year: 2017



Pulmonary tuberculosis relapse or atypical mycobacterium infection?
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012

Clinical analysis of pulmonary Mycobacterium kansasii disease
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018

Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
Source: Eur Respir J, 54 (1) 1801991; 10.1183/13993003.01991-2018
Year: 2019



Serological test and chest computed tomography findings in patients with mycobacterium avium-intracellulare (MAC) lung disease
Source: Annual Congress 2007 - Diagnostic tests and treatment in non cystic fibrosis bronchiectasis
Year: 2007



Clinical features of pulmonary Mycobacterium avium intracellulare complex disease with a solitary pulmonary nodule in Japan
Source: Eur Respir J 2005; 26: Suppl. 49, 687s
Year: 2005

Isolation of M. abscessus from patients with M. avium complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013

Paediatric lung transplant outcomes vary with Mycobacterium abscessus complex species
Source: Eur Respir J 2013; 41: 1230-1232
Year: 2013


Species-specific Interferon-Gamma Release Assay for the diagnosis of Mycobacterium abscessus complex infection in Cystic Fibrosis patients.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022



Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017